8.81 USD
↘ 0.61 (6.48%)AT CLOSE (11:59 AM EDT)
4D Molecular Therapeutics, Inc. Common Stock
FDMTNASDAQ • USD
8.87
↗ 0.06 (0.62%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
8.87
↗ 0.06 (0.62%)
Market: CLOSED
Open?$9.51
High?$9.51
Low?$8.72
Prev. Close?$9.42
Volume?850.0K
Avg. Volume?784.7K
VWAP?$8.90
Rel. Volume?1.08x
Bid / Ask
Bid?$8.73 × 100
Ask?$9.00 × 5.9K
Spread?$0.27
Midpoint?$8.87
Valuation & Ratios
Market Cap?480.9M
Shares Out?51.1M
Float?50.4M
Float %?88.3%
P/E Ratio?N/A
P/B Ratio?0.95
EPS?-$2.74
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?9.39Strong
Quick Ratio?9.39Strong
Cash Ratio?1.37Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score83/100
P/E?N/A▾
P/B?0.95CHEAP▾
P/S?5.64FAIR▾
P/FCF?N/A▾
EV/EBITDA?-2.7CHEAP▾
EV/Sales?4.94FAIR▾
Returns & Efficiency
ROE?-27.7%WEAK▾
ROA?-24.7%WEAK▾
Cash Flow & Enterprise
FCF?$-109618000
Enterprise Value?$420.7M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
Themes
Employees
196
Market Cap
480.9M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2020-12-11
Address
5858 HORTON STREET #455
EMERYVILLE, CA 94608
Phone: (510) 505-2680
EMERYVILLE, CA 94608
Phone: (510) 505-2680